Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease
Table 3
Statins, Beta-Blockers, and ACE Inhibitor medication compliance at one-year, Pharmacist Assisted Compliance Trial, Worcester Massachusetts, 2000–2005 ().
Condition
Control
intervention
-value
Mean (SD)
Mean (SD)
Statins
Number statin refills
6.13 (3.7)
179
6.35 (3.8)
196
.562
Statin CMA
0.90 (0.3)
162
0.88 (0.3)
173
.509
Number of prescriptions
2.41 (0.8)
223
2.55 (0.8)
238
.078
Total days on statin
290.53 (94.30)
179
291.20 (92.40)
196
.944
Beta Blockers
Number refills
5.80 (4.0)
189
6.34 (4.0)
207
.179
Beta-blocker CMA
0.91 (0.4)
157
0.97 (1.1)
180
.557
Total days on beta-blocker
283.19 (101.50)
189
287.55 (99.40)
207
.667
ACE Inhibitors
Number refills
5.73 (3.8)
146
6.23 (3.9)
179
.247
ACE CMA
0.93 (0.3)
126
1.02 (0.8)
157
.249
Total days on ACE
280.94 (93.40)
146
283.56 (95.00)
179
.803
% (Frequency)
% (Frequency)
Monthl statin prescription
69.83 (125)
179
70.41 (138)
196
.911
Monthl beta-blocker prescription
59.79 (113)
189
64.25 (33)
207
.407
Monthl ACE prescription
61.64 (90)
146
70.39 (126)
179
.1
*a: An indicator of whether all prescriptions for the medication were monthly (or less) prescriptions (versus 90 day or something >30 days at any time).
